Using AI to improve Alzheimer's treatment through the 'gut-brain axis'
Cleveland Clinic researchers are using artificial intelligence to uncover the link between the gut microbiome and Alzheimer's disease.
Apr 22, 2024
0
73
Cleveland Clinic researchers are using artificial intelligence to uncover the link between the gut microbiome and Alzheimer's disease.
Apr 22, 2024
0
73
Although there are still some aspects pending confirmation for its use in the clinical setting, and its resolution needs to be improved slightly, a study by the UPV/EHU and Biobizkaia has shown that a method routinely used ...
Apr 19, 2024
0
36
A large retrospective cohort pharmacoepidemiologic study found that despite approval by the U.S. Food and Drug Administration (FDA) for seven new gram-negative antibiotics between 2014 and 2019, clinicians in U.S. hospitals ...
Apr 19, 2024
0
2
It's long been recognized that some of the groups most likely to get dementia, including African Americans and Hispanics, are greatly underrepresented in clinical trials. Now a new USC study shows that people from certain ...
Apr 17, 2024
0
55
Alzheimer's disease (AD) currently afflicts nearly seven million people in the U.S. With this number expected to grow to nearly 13 million by 2050, the lack of meaningful therapies represents a major unmet medical need. Scientists ...
Apr 16, 2024
0
0
The Biden Administration announced Tuesday that it will work with 50 nations worldwide to try to prevent global pandemics such as COVID-19, which brought the world to a standstill four years ago.
Apr 16, 2024
0
0
In recent years, media and social networks have brought to light growing denunciations of obstetric and gynecological care that is considered violent, disrespectful, abusive or neglectful. These behaviors, words, acts and ...
Apr 16, 2024
0
14
In the space of three days, there have been two devastating knife attacks in Sydney. Your child may have seen these on the news or social media. Or they might be hearing about it from friends or at school.
Apr 16, 2024
0
5
Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory analysis of data from a ...
Apr 16, 2024
0
111
Alzheimer's disease (AD) remains one of the most challenging and prevalent neurodegenerative disorders, affecting millions of individuals worldwide. In a new study published in Developmental Cell, researchers from the lab ...
Apr 15, 2024
0
19